Sixpex packages cabergoline in 20-tablet sachets under the name Caberpex, each tablet dosed at 1 mg. The sachet format separates every tablet individually, and the oral form requires no reconstitution or injection equipment. Cabergoline is grouped under anti estrogen categories alongside compounds such as anastrozole, exemestane and clomiphene, though it operates through a different pathway. Sixpex, based in the USA, has produced these sachets since 2024.

20 Tablets at 1 mg Each in Sachet Packaging

The sachet holds 20 tablets, with 1 mg of cabergoline printed on the label for each. Other sachets in this category may carry 10 or 30 tablets, and some brands package cabergoline in blisters or bottles rather than sachets. Dosage strength for cabergoline across brands typically ranges from 0.5 mg to 1 mg per tablet, so Caberpex sits at the upper end of that range. The 20-count offers more tablets than a 10-count sachet but fewer than a 30-count blister, and the sachet format protects each tablet separately without the rigidity of a blister card.